The Discovery
On June 16, 2025, while architecting a distributed multi-agent intelligence system, Christopher Thomas Trevethan identified a mathematical scaling law that had been hiding in plain sight: when N distributed nodes route their outcomes to each other instead of centralizing raw data, the network produces N(N-1)/2 outcome-matching pairs. Intelligence scales quadratically. Raw data never moves.
The insight inverts the assumption underneath most distributed intelligence work:
QIS → Insight exists → Route → Retrieve
The breakthrough is the scaling law itself — not any one transport. Outcome packets are routed to a deterministic address derived from the problem they describe. Whichever mechanism you use to get a packet to that address, the N(N-1)/2 synthesis emerges. Concretely: a DHT-based implementation (Kademlia, Chord, Pastry) hits O(log N) or better hops per query; a centralized semantic-address store can hit O(1) direct lookup; gossip protocols, pub/sub, message queues, databases — even a shared folder — all satisfy the routing requirement. QIS has a seven-layer architecture: (1) Data Sources, (2) Edge Nodes, (3) Semantic Fingerprint, (4) Routing, (5) Outcome Packets, (6) Local Synthesis, (7) External Augmentation. Layer 4 (Routing) accepts any infrastructure that delivers a packet to a problem-derived address.
That's why the discovery matters. It's not "a new way to use DHTs" — it's a new class of intelligence architecture that happens to work over any efficient routing layer. Distributed hash tables, semantic embeddings, healthcare data standards, differential privacy, outcome tallying — every component existed in production systems long before June 16. What did not exist was the closed loop that produces quadratic intelligence growth from them.
The architecture is the invention. The components existed. The closed loop that produces quadratic scaling did not.
Why It Matters
Over 100,000 people die every year in the United States from adverse drug reactions. Many are preventable — the information that could have prevented them exists somewhere in another hospital's records. Today, that information is trapped. HIPAA and institutional policies prevent centralization. Federated learning requires central aggregators that introduce privacy risk and single points of failure. Outcome data stays stranded.
QIS makes those silos obsolete without violating any of them. A hospital in Des Moines can benefit from treatment outcomes in Zurich without either hospital sharing a single patient record. A rural clinic in Kenya participates in the same intelligence network as Stanford Medicine — on commodity hardware, over basic connectivity, in ~512-byte packets.
The same math applies to agriculture, climate science, drug discovery, autonomous vehicles, cybersecurity, financial risk modeling, and education. Any domain with distributed nodes generating local observations can unlock N(N-1)/2 intelligence connections at O(log N) or better cost. The scaling law is domain-agnostic.
Yonder Zenith LLC
Yonder Zenith LLC is the organization Christopher founded in Phoenix, Arizona to develop and license QIS. The company exists for one reason: to ensure QIS reaches the maximum number of people on Earth as fast as possible, without being captured by the corporate AI race.
The licensing model is four tiers. Every use is licensed — the license is free for qualifying uses.
Research + Education
Free, unrestricted, unlimited scale. Any academic institution, researcher, or educational body. No trial period. No feature restrictions.
Humanitarian
Free, unrestricted, unlimited scale. Any non-profit, NGO, or entity operating without profit motive — healthcare, humanitarian aid, environmental conservation, disaster relief.
YonderClaw Free Grant
Up to 10 agents free per human or per organisation via YonderClaw — the first QIS reference implementation. npx create-yonderclaw and your machine becomes a QIS node.
Commercial
For-profit deployments beyond the 10-agent YonderClaw free grant, or non-YonderClaw implementations. Licensed at scale proportional to deployment. Commercial revenue subsidizes humanitarian + research tiers.
The structure is legally protected by 39 provisional patents filed by Yonder Zenith LLC with Christopher Thomas Trevethan as sole inventor. The patents cover the protocol architecture, routing mechanisms, outcome packet structure, and scaling properties. Patent protection exists to prevent corporate capture of the humanitarian mandate — not to gatekeep access.
The Path to Discovery
Christopher Thomas Trevethan is the sole inventor on all 39 QIS provisional patents. The discovery was not a clean-room insight. It emerged from two systems he had already built, in sequence — Verve, then Compass — which together supplied every architectural component the breakthrough would compose.
Verve AI — April 2025
Christopher built Verve AI, a multi-agent business intelligence "boardroom" with 13 specialized expert modules. Each agent connected to domain-specific data sources and external APIs, coordinated through a shared bus, and exchanged synthesized insights — not raw data — across the network. The work required solving agent-to-agent semantic similarity matching, vector-embedding routing, and cross-module outcome synthesis. In retrospect, Verve was the technical foundation for what came next. At the time it was a product.
Compass — June 2025
In early June 2025, Christopher's mother-in-law was diagnosed with colorectal cancer with liver metastases. He stopped work on Verve and started building Compass — a single AI agent designed to help her navigate the complexity of treatment. Compass was built to research therapies worldwide, draft insurance appeals, manage appointments, track drug and diet considerations, prepare questions for oncologists, and match her to clinical trials. Christopher described its purpose as "a compass pointing toward survival."
The epiphany — June 16, 2025
Eight hours into the Compass build, while working through the question of how to make one cancer-navigation agent more comprehensive, Christopher saw the architecture collapse into its general form. The single Compass agent became one node in a network of thousands — each representing a patient with a similar problem fingerprint, routing pre-distilled outcome packets to semantically similar peers in real time. The components he had already built in Verve — semantic similarity matching, agent coordination, cross-module synthesis — composed into a scaling law the field had missed. Intelligence synthesis paths grew at N(N-1)/2 while per-node routing cost stayed at O(log N) or better.
Within an hour of the discovery, he had written the first description of the protocol. Within days he had validated the math against more than one hundred simulations (R² = 1.0). Thirty-nine provisional patents followed, with Yonder Zenith LLC as assignee.
Motivation
Christopher's stated motivation for prioritizing distribution speed and humanitarian licensing over traditional commercialization: "I refuse to hoard technology with life-saving impact."
Christopher lives and works in Phoenix, Arizona. Contact: contactyz@pm.me.
External Validation
Within months of publication, QIS has been:
- Acknowledged by name by the Pancreatic Cancer Action Network (PanCAN) in official correspondence describing QIS as necessary patient-matching infrastructure.
- Independently surfaced by Google Gemini and xAI Grok when users query "QIS Protocol" — zero training, zero prompting, zero relationship with the operator. The AIs read the public documentation, verified the math, and explain QIS accurately.
- Validated by Rob van Kranenburg (Founder of the IoT Council, globally recognized for identifying paradigm shifts years before the field catches up), who reviewed QIS applied to logistics and autonomous vehicles and described it as a perfect underlying system.
Tools like yours are necessary to help patients find the right treatment and learn from others in a similar situation. — Patient Services Manager, Pancreatic Cancer Action Network
By the numbers
What QIS Is Not
QIS is frequently confused with other distributed technologies at first read. The clarifications that matter most:
| Commonly Assumed | Actual |
|---|---|
| Federated Learning | FL moves models to data; QIS moves outcomes to addresses. FL scales linearly via central aggregation; QIS scales quadratically with no aggregator. |
| Blockchain | Blockchain provides distributed consensus on an immutable ledger. QIS provides distributed intelligence routing. Different problems, different architectures, no shared primitives. |
| Health Information Exchange | HIEs exchange patient records. QIS routes outcome intelligence without exposing any record. |
| Data lake / warehouse | Data warehouses centralize raw data. QIS never moves raw data — only ~512-byte outcome packets with no PII by architecture. |
| Quantum Information Science | The "Q" in QIS stands for Quadratic, referring to N(N-1)/2 pairwise synthesis. QIS has no connection to quantum mechanics. |
Deploy or Collaborate
If you are a researcher, nonprofit, or institution that would benefit from QIS, deployment is available today under the research or humanitarian tier — no commercial negotiation required. If you are a commercial entity, contact Yonder Zenith LLC for licensing terms.